Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06617949 · ClinicalTrials.gov registry record · Early Phase 1
Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.
A Early Phase 1 study of Substance Use Disorder (SUD), sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT06617949: Recruiting Early Phase 1 study of Substance Use Disorder (SUD), sponsored by Medical College of Wisconsin.
NCT06617949 is a Early Phase 1 study of Substance Use Disorder (SUD) that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 20 participants, below the 248-participant average among 15 other Substance Use Disorder (SUD) trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06617949, a Early Phase 1 study of Substance Use Disorder (SUD), is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to investigate the efficacy of three different modalities of post-operative pain control in parturient with opioid use disorders. The investigators aim to determine whether the different approach utilized show better outcomes with pain management and if there are any association with reduction of symptoms of anxiety, depression, and overall well-being.
Primary Outcome
Number of participants with significant change in pain assessment scores and any association with reduction of symptoms of anxiety, depression, and overall well-being.
Conditions Studied
Interventions
- DRUG Regional Anesthesia
- DRUG Hydromorphone Patient Controlled Analgelsic
- PROCEDURE Epidural local anesthetic infusion
Study Locations (2)
Wisconsin
- Froedtert Hospital Milwaukee, Wisconsin 53226 - Milwaukee
- Froedtert Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-01-16 |
| Est. Completion | 2028-12 |
| Phase | Early Phase 1 |
What NCT06617949 shows while recruiting
NCT06617949 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 248-participant average among 15 other Substance Use Disorder (SUD) trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Substance Use Disorder (SUD) appearing as the primary indexed condition, and to 3 interventions - of which Regional Anesthesia is the first listed.
NCT06617949 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06617949 about?
NCT06617949 is a clinical study titled "Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.". The purpose of this study is to investigate the efficacy of three different modalities of post-operative pain control in parturient with opioid use disorders. The investigators aim to determine whether the different approach utilized show better outcomes with pain management and if there are any ass...
What is the current status of trial NCT06617949?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2025-01-16. Estimated completion is 2028-12.
What conditions does trial NCT06617949 study?
This clinical trial studies the following conditions: Substance Use Disorder (SUD).
What interventions are being tested in trial NCT06617949?
The interventions under investigation include: Regional Anesthesia (DRUG), Hydromorphone Patient Controlled Analgelsic (DRUG), Epidural local anesthetic infusion (PROCEDURE).
Who is sponsoring clinical trial NCT06617949?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06617949 being conducted?
This trial has 2 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorder (SUD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06617949's enrollment target sits among peer trials
20 15th of 15 higher than 1 of 15 other Substance Use Disorder (SUD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorder (SUD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Open-Label Psilocybin Study in Transdiagnostic Population
RECRUITING · Phase 1
-
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
RECRUITING · Phase 4
-
Contingency Management for Veteran Smokers Undergoing Major Elective Surgery
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
California MEPS Hub
RECRUITING · NA
-
Substance Use in Pregnant People - Optimizing Retention in Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI